Wuhan Coronavirus Resource Thread

[disha]

1.8 Million sounds plausible - i am hearing too many deaths from social circles in chennai. multiple in the same family. the worst case is to look at the overall death rate and calculate the worst case by giving it a % due to covid - what if 80% is due to covid? other causes due to infection/accident etc are way low now...

Any numbers based on anecdote and hearsay must be discounted. As much by 6x.

Think about it, you are moving in say 6 social circles. Some one from one of that social circle is also member of the social circles of all the other five social circles. You want a more formal discourse? https://en.wikipedia.org/wiki/Six_degrees_of_separation

Now you hear from one social circle that person 'X' related to person 'Y' who happens to be friend of your friend person 'Z' passed away. The same is magnified 6x times across all your social circles, not necessarily by you, but someone who you know.

Hence one innocent unfortunate death is magnified 6x times.

Now V_Raman'ji, how can you explain that the total deaths in Delhi 2020 were less than the total deaths in Delhi 2021?

Also how do you count the death of a person who recovers from Covid but is done by say heart attack due to significant decrease in lung function? Is it covid death? Or not?

It is true that it is difficult in India nowadays to under count the death numbers. Mis counting can happen like above. And again the natural instinct of an Indian is to hide all cardiovascular diseases (no person has diabetes, heart issues, cholesterol etc problems), and it when they pass away due to that, it is good to go and declare that the person passed away due to covid.

[saip]

^^^ I agree. My own personal experience shows - all deaths (6) are counted but may be in one misreported as Natural cause. He a retd Col. admitted to MH, discharged as recovered, passed away 3 days later of cardiac arrest. DCert said NCause.

[IndraD]

after sinopharm, now sinovac approved by WHO on US watch

[Tanaji]

Gagandeep Kang interview

https://indianexpress.com/audio/the-san ... y/7336046/

Not much new information there for the close followers of this thread.

[Suraj]

after sinopharm, now sinovac approved by WHO on US watch

The WHO EUL enables COVAX supply. The Chinese hope to be major suppliers here, though it's unclear if they can sustain production volumes both for a domestic surge and developing market export drive. Covaxin won't hit its production stride until Aug anyway, and it should have its own WHO EUL by then, enabling Bharat Biotech to supply it to COVAX initiatives if there's production in excess of Indian domestic demand.

[disha]

^ Gems for the emperor penguins from the above interview

Now, the question really is, what do these data mean when you have B.1.617.2 circulating? Now in the UK, a decision has been made to reduce the gap between the two AstraZeneca doses to eight weeks, particularly in older individuals. Again, important to place this in context. In the UK, they have pretty much managed to finish immunizing older individuals with a single dose. They followed a very strictly age descending strategy, so right now they are offering bookings for immunization for people who are in their mid 30s.

For the mudiwhomustrezine campers

There are also data that come from the phase three clinical trials where the best efficacy was seen in those who received the vaccination after 12 weeks.

What we should be doing and absolutely must do in India is to make sure that no doses of vaccine go to waste.

^^ Read the amount of vaccines wasted in Rajasthan

And back to emperor penguins:

Should we go with what we could call a spray and pray approach, where you get a tiny dose of vaccines in any demographic and that’s an equitable way to do it? Or should we be thinking about concentrating vaccination in specific areas? Or specific populations to be able to really answer questions on the impact of vaccination? And in a situation of limited supply these are choices that we have to make.

Anyway, emperor penguins declared that older populations do not matter. So please go and tell your grand parents that they have lived their life and must not be vaccinated. Those were the words of emperor penguins. My interpretation of their words: "Grandparents can go and die without vaccinations".

Added later, Kang should really use her grey cells before making this statement

It seems now from communications that are publicly available that the Centre is keeping the 50% that it had allocated to itself, but is also deciding on the allocations that go to the state. So even though the state is buying it, the number of doses is decided not by the company, but by the Centre. So that seems even more confusing to me and nobody is sure what number of doses are going to the private sector.

Yet it does look like you can get appointments for a private sector vaccination much easier than you can get a free vaccine in a state. And that private sector vaccination seems to be available to some of the larger hospital chains, but maybe not elsewhere. So I really don’t know what’s going on.

Just two statements back, she was talking about specific population. So Kang, how will one ensure that specific population gets the vaccine first? And take the case of HIV. Who were targetted? Truck drivers and Dhaba stops with red light areas. That brought down the entire HIV 'pandemic' numbers. To the disappointment of several NGOs.

Similarly who should be targetted? Apart from front line workers and health care workers, it must be >45 years and within that >60 years if no comorbidities in urban clusters.

But then opposition and Kang included will ridicule the government and waste vaccines and also spread vaccine hesitancy.

[Kakkaji]

SII may make Sputnik V in India

India’s COVID-19 vaccination drive could get a booster shot if Serum Institute of India (SII) is able to get regulatory clearances to make the Russian Sputnik V vaccine locally. This would be the third vaccine from the SII stable after AstraZeneca’s Covishield and Novovax’s Covovax.

SII has sought permission from the Drug Controller General of India (DCGI) and has submitted an application, (C-10), on Wednesday for test analysis and examination. Once these permissions are received, an emergency use authorisation (EUA) would be required.

Currently, Dr Reddy’s Laboratories has a tie-up with the Russian Direct Investment Fund (RDIF) to make the Sputnik V Covid vaccine in India.
Dr Reddy’s received the EUA for Sputnik V in India on April 13 and also permission from DCGI to import the Russian vaccine.The first lot of the vaccines has been imported with three million units arriving in the country on Tuesday.

The imported doses ofSputnik-V are priced at `995.40 per dose and Dr Reddy’s has indicated prices would be lower once local supplies begin. The first lot of Sputnik vaccines made in India has received clearance on Tuesday from the Central Drug Laboratory, Kasauli.

SII has committed to make 100 million Covishield vaccines a month from June. It has started manufacturing the Novavax vaccine, in small batches, at its Pune plant, even as it awaits regulatory clearance in the US and subsequently in India.

[Amber G.]

Protein subunit type vaccine
India gov't seals deal for 300 mln Biological-E COVID-19 vaccine doses

India's government said on Thursday it has inked a deal with domestic vaccine maker Biological-E for 300 million COVID-19 vaccine doses for 15 billion rupees ($205.62 million).

The vaccine, which is currently undergoing phase-3 clinical trials, will likely to be available in the next few months, the health ministry said in a statement.

[Deans]

Please avoid throwing anecdotes around. The topic is controversial as it is, and anecdotes offer no actionable information. Here's an example of an evidence-based analysis of the topic:
An Evidence-Based Estimation Of Covid Deaths That Is Far Better Than NYT’s

Hard to understand that article.

It could be better written. My take from what its trying to say is:
- Covid deaths have been undercounted everywhere. In India it will probably be to a higher extent, as there is inadequate record keeping &
testing particularly in rural India. But even in a worst case scenario, deaths are nowhere near what NYT assumes.
- NYT's logic is based on ' if 50 out of 100 people in a nursing home in Delhi test positive at some time (which has happened often enough in the US), it can be extrapolated to mean half of India was infected.
- The most accurate way to measure possible Covid deaths is to compare total deaths before and after covid. There is data available for wave 1.
In many States, total deaths in 2020 are actually LOWER than 2019 (adjusting for pop growth). Assuming every extra death in places like Mumbai
and Delhi (where 2020 deaths were significantly more than 2019) is due to Covid, it would mean actual deaths (in those cities, not the whole of India) were upto 2X of what was reported.

[nandakumar]

Was reading the SC order (J Chandrachud) yesterday. Essentially it asks the Centre the following:
The data on the percentage of population that has been vaccinated (with one dose and both doses), as against eligible persons in the first three phases of the vaccination drive. This shall include data pertaining to the percentage of rural population as well as the percentage of urban population so vaccinated;
The complete data on the Central Government‟s purchase history of all the COVID-19 vaccines till date (Covaxin, Covishield and Sputnik V). The data should clarify: (a) the dates of all procurement orders placed by the Central Government for all 3 vaccines; (b) the quantity of vaccines ordered as on each date; and (c) the projected date of supply; and
An outline for how and when the Central Government seeks to vaccinate the remaining population in phases 1, 2 and 3.
The steps being taken by the Central Government to ensure drug availability for mucormycosis.

We also note that UoI‟s stated position in its affidavit dated 9 May 2021 is that every State/UT Government shall provide vaccination free of cost to its population. It is important that individual State/UT Governments confirm/deny this position before this Court. Further, if they have decided to vaccinate their population for free then, as a matter of principle, it is important that this policy is annexed to their affidavit, so that the population within their territories can be assured of their right to be vaccinated for free at a State vaccination centre. Hence, we direct each of the State/UT Governments to also file an affidavit within 2 weeks, where they shall clarify their position and put on record their individual policies.
These are fairly innocuous directions. In the sense that the context is one of shortage in vaccine availability. Absent such a shortage, the underlying premise for the SC duo moto cognisance of the issue falls through. The order directs the Government to file its reply by 15th June. If by then there is greater clarity on vaccine production ramp up occurs by middle of this month then there is nothing to see. The Court and the public can move on.

[Suraj]

SC is wasting time demanding so much stuff that's readily available in the public domain in the news, on CoWin and elsewhere. They're acting like they're demanding gayatri mantra when most of this stuff is widely known already, even I posted every order information so far on Twitter.

[Pratyush]

^^^

It would appear that everyone wants to be seen doing something in order to get the GOI to show progress. At the expense of the GOI which is doing all the heavy lifting.

[arshyam]

SC is just grandstanding, as is their wont of late.

[Pratyush]

Biological-E COVID-19 vaccines may be available in few months as Centre pays advance for 30 crore doses

This seems to be a 4th vaccine that GOI has ordered.

Union Ministry of Health has finalised arrangements with Hyderabad-based vaccine manufacturer Biological-E to reserve 30 crore of COVID-19 vaccine doses.

Biological-E COVID-19 vaccine is an RBD protein sub-unit vaccine

They are also working on a separate Canadian vaccine as well.

PROVIDENCE THERAPEUTICS HOLDINGS INC. OF CANADA AND BIOLOGICAL E. LIMITED OF INDIA ANNOUNCE THE EXECUTION OF A TERM SHEET FOR THE LICENSING AND COLLABORATION OF MRNA VACCINE

The plan is to produce 600 Million doses at minimum in the next 12 months.

After Biological E, Here is a List of India-Made Vaccines that May be Rolled Out Soon

Slightly dated but still relevant

Gujarat: Zydus Cadila now plans to test its Covid-19 vaccine ..

In the next few months it seems that we will be quite well placed in terms of vaccine availability.

The opposition and the judiciary will take the credit but it is the Indian companies that will have delivered.

[IndraD]

Canada

#BREAKING: The National Advisory Committee on Immunization says people who have been given the viral-vector AstraZeneca shot can be given a Pfizer or Moderna mRNA shot as their second shots. https://twitter.com/CityNews/status/139 ... 78214?s=20

[IndraD]

Bahrain, Facing a Covid Surge, Is Giving Pfizer Boosters to Recipients of Chinese Vaccine. It had fully vaccinated 47% pop with Sinopharm
Daily Covid deaths have leapt to 12/million people in recent weeks—an outbreak nearly 5 times more lethal than India
https://www.wsj.com/articles/bahrain-fa ... 1622648737

[Uttam]

Bahrain, Facing a Covid Surge, Is Giving Pfizer Boosters to Recipients of Chinese Vaccine. It had fully vaccinated 47% pop with Sinopharm
Daily Covid deaths have leapt to 12/million people in recent weeks—an outbreak nearly 5 times more lethal than India
https://www.wsj.com/articles/bahrain-fa ... 1622648737

Some more details from the above news article:

The two Chinese vaccines are manufactured with inactivated virus

In a separate, unpublished, real-world study of Sinopharm in Serbia, 29% of 150 participants were found to have zero antibodies against the virus three months after they received the first of two shots of the vaccine. The average age of the people who participated in the Serbian study was higher than 65.

Seems like the Chinese vaccines are ineffective for 65 and above, the population most vulnerable to Covid.

[Uttam]

ignore this post. I overwrote it while posting new update.

[Suraj]

Almost 3m again on Thursday after the customary slowdown we see on Tuesday and Wednesday almost every single week so far.

[vijayk]

Almost 3m again on Thursday after the customary slowdown we see on Tuesday and Wednesday almost every single week so far.

We need to bump it to 4 to 5 because SII is promising 10-12 cr doses and BB another 5 cr this month.

[Suraj]

Not a question of supply but strategy in my view. Since March, essentially every week, the vaccination rate goes down between Tuesday and Thursday and then rises. People appear to be unable to go get vaccinations midweek due to work demands. Those of us who have looked at the daily vaccinations have seen this behavior for a long time now. Every country has similar localized behavior where some days are better.

This means these days are ripe for a different approach to be implemented where vaccination drives target those traveling to work or are otherwise professionally engaged in a workplace setting.

[Amber G.]

^^^ Wewill see if it pans out, but indications are that we, in India, will see vaccines rate about 4-5 millions/day fairly quickly and it will increase to 10 millions per day in 4-5 weeks. People behind the scene are *quietly* doing hard work so I think they are going to succeed. (China is currently doing something like 20M/day - we can easily do that too)

(There have been good mathematical models to advice how the vaccine distribution ought to be done - unfortunately there is too much noise and people don't let good people do their work).

[vijayk]

[Suraj]

^^^ Wewill see if it pans out, but indications are that we, in India, will see vaccines rate about 4-5 millions/day fairly quickly and it will increase to 10 millions per day in 4-5 weeks. People behind the scene are *quietly* doing hard work so I think they are going to succeed. (China is currently doing something like 20M/day - we can easily do that too)

(There have been good mathematical models to advice how the vaccine distribution ought to be done - unfortunately there is too much noise and people don't let good people do their work).

The earlier response was specific vaccination rate trend showing a drop midweek. It has been invariant to supply, and has been a visible trend since March when general vaccinations began. That is why I stated that there's no data to suggest the midweek slump is a supply issue; it's more a matter of people being busy to go to vaccination centers, and it's a time of week where a vaccination drive going to the people (instead of making them come to the center) makes most sense and potential impact.

[Uttam]

Biden announces first 25 million vaccine doses going to India, others facing 'surges'

President Joe Biden announced on Thursday the first details of the U.S. sending 80 million COVID-19 vaccines overseas with the aim of "ending the pandemic globally."

"At least 75 percent of these doses—nearly 19 million—will be shared through COVAX, including approximately 6 million doses for Latin America and the Caribbean, approximately 7 million for South and Southeast Asia, and approximately 5 million for Africa, working in coordination with the African Union and the Africa Centres for Disease Control and Prevention.

The remaining doses, just over 6 million, will be shared directly with countries experiencing surges, those in crisis, and other partners and neighbors, including Canada, Mexico, India, and the Republic of Korea," he said.

White House Coronavirus Response Coordinator Jeff Zients said the donations would be "surplus" from the supply the U.S. needs and would include the FDA-approved Pfizer, Moderna and Johnson & Johnson vaccines, but not the Astra Zeneca vaccine.

[IndraD]

The White House says it will lift the Defense Production Act ratings on the AstraZeneca, Novavax, and Sanofi COVID19 vaccines https://twitter.com/ANI/status/1400493641529905153?s=20

US will gift 80 million vaccines to the countries hit with surges immediately , India will get 25 million.

[Suraj]

^^^
Despite the US embargo until now, its worth being being clear on the quantitative measures involved.
- in the 1.5 months since the US started talking about removing DPA India has produced over 125 million vaccines
- despite the DPA and import dependence, India has produced close to 350 million vaccines to date
- India had already exported almost 70m vaccines including COVAX commitments.
- SII started making AZ vaccine at-risk before EUA and despite US material embargo in Nov 2020. It is now doing the same with Novavax . This is despite a US funded COVAX initiative disrupted by a US driven embargo on materials.

[Uttam]

NIH scientists say they may have found a promising new oral antiviral drug for Covid

The drug, called TEMPOL, can reduce Covid-19 infections by impairing an enzyme the virus needs to make copies of itself once inside human cells, the NIH said.

The NIH researchers said they plan to conduct additional preliminary studies and will seek opportunities to evaluate the drug in a clinical study of Covid.

The study’s findings were “hopeful,” said Dr. Tracey Rouault, another NIH official who led the study.

“However, clinical studies are needed to determine if the drug is effective in patients, particularly early in the disease course when the virus begins to replicate.”

[Amber G.]

Genomic characterization and Epidemiology of an emerging SARS-CoV-2 variant in Delhi, India
Three takeaways for now are:

1) Delta (B.1.617.2) is more transmissible than Alpha (B.1.1.7).
2) There seems to be greater immune escape and reinfection.
3) Fully vaccinated breakthroughs were disproportionately due to Delta.

Abstract:
In April 2021, after successfully enduring three waves of the SARS-CoV2 pandemic in 2020, and having reached population seropositivity of about 50%, Delhi, the national capital of India was overwhelmed by the fourth wave. Here, we trace viral, host, and social factors contributing to the scale and exponent of the fourth wave, when compared to preceding waves, in an epidemiological context. Genomic surveillance data from Delhi and surrounding states shows an early phase of the upsurge driven by the entry of the more transmissible B.1.1.7 variant of concern (VOC) into the region in January, with at least one B.1.1.7 super spreader event in February 2021, relatable to known mass gatherings over this period. This was followed by seeding of the B.1.617 VOC, which too is highly transmissible, with rapid expansion of B.1.617.2 sub-lineage outpacing all other lineages. This unprecedented growth of cases occurred in the background of high seropositivity, but with low median neutralizing antibody levels, in a serially sampled cohort. Vaccination breakthrough cases over this period were noted, disproportionately related to VOC in sequenced cases, but usually mild. We find that this surge of SARS-CoV2 infections in Delhi is best explained by the introduction of a new highly transmissible VOC, B.1.617.2, with likely immune-evasion properties; insufficient neutralizing immunity, despite high seropositivity; and social behavior that promoted transmission.

[Amber G.]

This is an excellent opinion piece by Dr. Anurag Agrawal in Nature, Director of IGIB in New Delhi. Worth reading.
India’s COVID crisis flags need to forecast variants

[vijayk]

[Kakkaji]

The logistics are being put in place for Sputnik V:

Sputnik V: Snowman Logistics in pact with Dr Reddy’s Laboratories

It can store up to 650 million doses and ramp-up to 1.05 billion doses at short notice.

Integrated temperature-controlled logistics service provider, Snowman Logistics, has entered into a strategic partnership with Dr Reddy’s Laboratories Ltd to deliver the Russian two-dose Covid-19 vaccine, Sputnik V, across the country.

Snowman will manage the delivery through five of its high-capacity temperature-controlled warehouses in Mumbai, Delhi-NCR, Kolkata, Chennai, and Bengaluru and offer storage, order processing, shipper packing and secondary transportation from these locations.

The locations are strategically located to take care of the state distribution and the whole of the regional requirements. The temperature throughout will be maintained between -20 degrees Celsius and -25 degrees Celsius.

The company can store at up to -80 degrees Celsius and provide real-time temperature monitoring to ensure the right conditions for vaccine distribution during the entire supply chain.

In addition, the company has a capex plan of roughly ₹425 crores for capacity expansion, with a focus on the Pharma and E-Commerce sector where the company has seen huge increases in demand since the onset of the pandemic, especially as there is a dearth of capacities in the organised sector.

Dr Reddy has been working on a solution where they can supply a week's supply of doses to a vaccination site in a special 'freezer box' that can maintain the required temparature. At the end of the week they will replace these doses with fresh supply for a week.

If their logistics solution can bring back the smaller private hospitals and diagnostic centers in these five metro cities that dropped out of the vaccination loop during Phase 3, it will be a great outcome.

[Kakkaji]

Stalin woos Bharat Bio to set up vaccine unit in TN

Tamil Nadu Chief Minister MK Stalin on Thursday chaired a meeting with representatives of Bharat Biotech over setting up a vaccine manufacturing unit in the State.

Though no information about the meeting was shared, officials said that the discussion was around the possibility of setting up a greenfield project.

The development comes a day after Stalin wrote to Union Health minister Harsh Vardhan emphasising the urgency in getting HLL Bio-Tech’s Integrated Vaccine Complex at Chengalpattu operational.

It is not clear if the Integrated Vaccine Complex featured in the discussion with Bharat Bio. The Hyderabad-based vaccine-maker’s could not be reached for a comment.

[Kakkaji]

Malabar Gold to contribute 1 lakh free Covid vaccines

The vaccination drive will be held at the company premises and through tie-ups with leading hospitals administering WHO approved vaccines
With a mission to strengthen the fight against the pandemic, the jewellery retailer Malabar Gold & Diamonds has decided to contribute one lakh free Covid-19 vaccines.

The vaccines will be administered for people who are vulnerable to the disease with limited access to the vaccine apart from jewellery artisans, employees, investors and their dependents. This programme is part of a series of CSR initiatives Malabar Gold & Diamonds have been working on during the pandemic.

“We have earmarked ₹8 crore for the vaccination drive and this initiative is the first step in our contribution to the nation-wide vaccination drive. We will use our services and infrastructure to reach out to and vaccinate those who are most vulnerable to the disease. This includes the elderly and those with chronic illnesses who will be identified through charitable associations and likeminded organizations” MP Ahammed, Chairman, Malabar Group said.

The vaccination drive will be held at the company premises and through tie-ups with leading hospitals administering WHO approved vaccines, he said.

[pgbhat]

Exclusive: How Amateur Sleuths Broke the Wuhan Lab Story and Embarrassed the Media

Entire thing is a good read.

One important piece was an extensive Medium post by the Canadian longevity entrepreneur Yuri Deigin that discussed RaTG13, a virus Shi Zhengli had revealed to the world in a February 3 paper in the journal Nature. In that paper, Shi presented the first extensive analysis of SARS-CoV-2, which had seemed to come from nowhere—the virus was unlike any that had been seen before, including the first SARS, which had killed 774 people from 2002 to 2004. In her paper, however, Shi also introduced RaTG13, a virus that is similar in genetic makeup to SARS-CoV-2, making it the only known close relative at the time.

The paper was vague about where RaTG13 had come from. It didn't say exactly where or when RaTG13 had been found, just that it had previously been detected in a bat in Yunnan Province, in southern China.

The paper aroused Deigin's suspicions. He wondered if SARS-CoV-2 might have emerged through some genetic mixing and matching from a lab working with RaTG13 or related viruses. His post was cogent and comprehensive. The Seeker posted Deigin's theory on Reddit, which promptly suspended his account permanently.

In a profile in Scientific American, Shi Zhengli acknowledged working in a mineshaft in Mojiang County where miners had died. But she avoided connecting it to RaTG13 (an omission she had made in her scientific papers as well), claiming that a fungus in the cave had killed the miners.

That explanation didn't sit well with the DRASTIC group. They suspected a SARS-like virus, not a fungus, had killed the miners and that, for whatever reason, the WIV was trying to hide that fact. It was a hunch, and they had no way of proving it.

At this point, The Seeker revealed his research powers to the group. In his online explorations, he'd recently discovered a massive Chinese database of academic journals and theses called CNKI. Now he wondered if somewhere in its vast circuitry might be information on the sickened miners.

Working through the night at his bedside table on phone and laptop, fueled by chai and using Chinese characters with the help of Google Translate, he plugged in "Mojiang"—the county where the mine was located—in combination with every other word he could think of that might be relevant, instantly translating each new flush of results back to English. "Mojiang + pneumonia"; "Mojiang + WIV"; "Mojiang + bats"; "Mojiang + SARS." Each search brought back thousands of results and half a dozen different databases for journals, books, newspapers, master's theses, doctoral dissertations. He combed through these results, night after night, but never found anything useful. When he ran out of energy, he broke for arcade games and more chai.

[vijayk]

3.5 M today from COWIN dashboard

[vijayk]

MUST READ FOR ALL

Exclusive: How Amateur Sleuths Broke the Wuhan Lab Story and Embarrassed the Media

Entire thing is a good read.

One comment

While this article is a great start, there is so much missing. Peter Dazak is on record talking about making coronaviruses more infectious and transmittable through WIV connections. He was only a small part of the interconnect with WIV, Fauci is also front and center. "Fauci's NIAID awarded the grant that funded Wuhan lab to genetically modify bat-based coronaviruses 04/08/2021 / By Nolan Barton" None of this is even remotely new, Dr. Joseph Mercola has a book out about it but the mainstream "Fact Checkers" google, facebook, twitter etc., have all banned him because of his disclosure of the truth.

This is really a great opportunity for GOI to investigate FB, Twitter and reddit of they violated people's rights and helped the holocaust by these scums

[Uttam]

More than 33 lakh Vaccine Doses administered today till 7 pm

Cumulative Vaccine Coverage exceeds 22.75 Crore



Cumulative Day 140 (22.75) - Day 139 (22.37cr) = 38 lakh doses. (morning update pending)

Is my calculation correct? Usually, the difference between 7pm and next day 8am figures is only about 3 lacs but this time is if more than 10 lacs.

Maybe, some prior vaccinations were tallied up today!

[darshan]

We haven't heard anything further about Manipal University and US funded research.

https://gvn.org/about/
WE GATHER in Washington, D.C. to support goals and ideals of the Global Virus Network, a new approach to fostering true collaboration among all regions and all peoples of the world.
Seeking to improve the immediate responses to emerging viral threats, train future generations of medical virologists, and advise governments or non-governmental organizations on viral disease threats and their control, the Global Virus Network fills a critical need in international health for today and into the future.

Signed this day March 3, 2011, Washington, D.C.

[Suraj]

Day 139: https://www.pib.gov.in/PressReleasePage ... ID=1724195
Day 140: https://www.pib.gov.in/PressReleasePage ... ID=1724521

22,75,67,873 - 22,37,27,632 = 38,40,241

3.85 million on Friday.